ENTA
Enanta Pharmaceuticals Inc
NASDAQ: ENTA · HEALTHCARE · BIOTECHNOLOGY
$13.87
+1.17% today
Updated 2026-04-29
Market cap
$386.25M
P/E ratio
—
P/S ratio
5.77x
EPS (TTM)
$-3.21
Dividend yield
—
52W range
$5 – $17
Volume
0.2M
Enanta Pharmaceuticals Inc (ENTA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |